Assessing gene function in human B cells: CRISPR/Cas9‐based gene editing and mRNA‐based gene expression in healthy and tumor cells-Reference-Cited by-同舟云学术

Assessing gene function in human B cells: CRISPR/Cas9‐based gene editing and mRNA‐based gene expression in healthy and tumor cells

Published:2022-05-22 Issue:8 Volume:52 Page:1362-1365
ISSN:0014-2980
Container-title:European Journal of Immunology
language:en
Short-container-title:Eur J Immunol

Author:

Nardi Federica¹²^ORCID,Pezzella Laura¹,Drago Roberta¹²,Di Rita Anthea¹³,Simoncelli Martina²⁴,Marotta Giuseppe⁵,Gozzetti Alessandro²⁴,Bocchia Monica²⁴,Kabanova Anna¹^ORCID

Affiliation:

1. Toscana Life Sciences Foundation Siena Italy

2. Department of Medicine Surgery and Neuroscience University of Siena Siena Italy

3. Department of Life Sciences University of Siena Siena Italy

4. Hematology Unit University of Siena Siena Italy

5. Stem Cell Transplant and Cellular Therapy Unit University Hospital of Siena Siena Italy

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/eji.202149784

Reference9 articles.

1. Evidence for an alternative fatty acid desaturation pathway increasing cancer plasticity

2. A Simple, Highly Efficient Method for Heterologous Expression in Mammalian Primary Neurons Using Cationic Lipid-mediated mRNA Transfection

3. Highly Efficient Reprogramming to Pluripotency and Directed Differentiation of Human Cells with Synthetic Modified mRNA

4. Engineering Protein-Secreting Plasma Cells by Homology-Directed Repair in Primary Human B Cells

5. Integrative taxonomy resolves taxonomic uncertainty for freshwater mussels being considered for protection under the U.S. Endangered Species Act

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Robust and cost‐effective CRISPR/Cas9 gene editing of primary tumor B cells in Eµ‐TCL1 model of chronic lymphocytic leukemia;HemaSphere;2024-08

2. NFKBIE mutations are selected by the tumor microenvironment and contribute to immune escape in chronic lymphocytic leukemia;Leukemia;2024-03-15

3. Robust CRISPR-Cas9 Genetic Editing of Primary Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma Cells;HemaSphere;2023-06